Our newest edition EMJ Diabetes 7.1 provides a compendious review of the congress, along with a selection of peer-reviewed articles and interviews from experts in the field.
EMJ Diabetes 7.1 2019
Latest articles
All articles
6 Mins
25th
October
Interview: Samuel Seidu
The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with respect to the newer diabetes therapies, sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists.
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
25th
October
The Impact of Gestational Diabetes on Long-Term Kidney Disease
Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse outcomes. Recent…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
6 Mins
25th
October
Consequences of Disintegrated Care for Dual Tuberculosis and Diabetes
Diabetes is known to be a risk factor for active pulmonary tuberculosis (TB) and the reactivation of latent or previous TB. It is also…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.